Yesterday, Feb. 17, 2016, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.30 to $7,252,323.17.

Highlighted Stocks Traded by Insiders:

Macerich (MAC) - FREE Research Report

O Hern Thomas E, who is Senior EVP, Treasurer & CFO at Macerich, sold 5,000 shares at $75.66 on Feb. 17, 2016. Following this transaction, the Senior EVP, Treasurer & CFO owned 51,377 shares meaning that the stake was reduced by 8.87% with the 5,000-share transaction.

The shares most recently traded at $76.53, up $0.87, or 1.14% since the insider transaction. Historical insider transactions for Macerich go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 1,000

The average volume for Macerich has been 1.1 million shares per day over the past 30 days. Macerich has a market cap of $12.0 billion and is part of the financial sector and real estate industry. Shares are down 6.07% year-to-date as of the close of trading on Wednesday.

The Macerich Company is an independent real estate investment trust. The firm invests in the real estate markets of the United States. The stock currently has a dividend yield of 3.6%. The company has a P/E ratio of 24.5. Currently, there are 3 analysts who rate Macerich a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MAC - FREE

TheStreet Quant Ratings rates Macerich as a buy. Among the primary strengths of the company is its expanding profit margins over time. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Macerich Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Molina Healthcare (MOH) - FREE Research Report

Schapiro Richard M, who is Director at Molina Healthcare, bought 1,000 shares at $56.00 on Feb. 17, 2016. Following this transaction, the Director owned 3,272 shares meaning that the stake was boosted by 44.01% with the 1,000-share transaction.

The shares most recently traded at $60.68, up $4.68, or 7.71% since the insider transaction. Historical insider transactions for Molina Healthcare go as follows:

  • 4-Week # shares sold: 20,570
  • 12-Week # shares sold: 20,570
  • 24-Week # shares sold: 36,503

The average volume for Molina Healthcare has been 866,800 shares per day over the past 30 days. Molina Healthcare has a market cap of $3.3 billion and is part of the health care sector and health services industry. Shares are down 1.51% year-to-date as of the close of trading on Wednesday.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The company operates through two segments, Health Plans and Molina Medicaid Solutions. The company has a P/E ratio of 22.6. Currently, there are 7 analysts who rate Molina Healthcare a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOH - FREE

TheStreet Quant Ratings rates Molina Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Molina Healthcare Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Time (TIME) - FREE Research Report

Fahey John M Jr, who is Director at Time, bought 3,000 shares at $12.80 on Feb. 17, 2016. Following this transaction, the Director owned 17,370 shares meaning that the stake was boosted by 20.88% with the 3,000-share transaction.

The shares most recently traded at $13.96, up $1.16, or 8.3% since the insider transaction. Historical insider transactions for Time go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 2,515
  • 12-Week # shares bought: 3,400
  • 12-Week # shares sold: 2,515
  • 24-Week # shares bought: 10,400
  • 24-Week # shares sold: 2,515

The average volume for Time has been 1.2 million shares per day over the past 30 days. Time has a market cap of $1.5 billion and is part of the services sector and media industry. Shares are down 10.53% year-to-date as of the close of trading on Wednesday.

Time Inc., together with its subsidiaries, operates as a media company that publishes magazines in the United States, the United Kingdom, and internationally. The stock currently has a dividend yield of 5.68%. The company has a P/E ratio of 12.2. Currently, there are 2 analysts who rate Time a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TIME - FREE

TheStreet Quant Ratings rates Time as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Time Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.